Burcon NutraScience Corp BRCNF

 — 
1.00 0.09 9.89% as of 25 Sep
Market cap
—
P/E
0.0×
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 Mar '18 Mar '17
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
10.76 37.09 84.20 64.97 583.42 1,551.93 1,727.78 189.55 194.60 409.13
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(8.11) (0.28) (16.64) (21.45) (46.17) 5,993.36 (268.56) (7.50) (7.71) (31.00)
P/B ratio
0.00 2.04 5.62 5.71 3.54 11.21 2.33 0.00 4.06 8.73
Price to Tangible BV
0.00 2.49 7.44 8.20 3.71 11.61 2.47 0.00 8.74 12.57
EV/Sales
20.98 74.40 94.34 78.54 549.18 1,503.40 1,500.87 257.09 163.65 376.30
EV/EBITDA
0.00 43.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(5.18) (0.51) (5.62) (4.75) (15.92) (129.82) (16.99) (2.49) (1.73) (7.17)
EV/FCF
(4.69) (0.49) (5.50) (4.48) (15.79) (100.25) (16.38) (2.48) (1.73) (6.96)
Quick Ratio
0.13 1.72 3.54 2.86 7.02 9.89 9.65 0.14 4.14 6.81
Current Ratio
0.19 1.82 3.83 2.98 7.30 10.09 9.91 0.21 4.41 7.06
Net Debt/EBITDA
(2.37) 22.06 (0.35) (0.54) 0.99 3.12 2.25 (0.17) 0.28 0.52
Debt/Assets
104.77% 70.15% 49.60% 51.89% 0.20% 0.00% 21.53% 50.74% 35.04% 26.77%
Debt/Equity
(4.15) 3.10 1.24 1.24 0.00 0.00 0.29 (0.63) 0.81 0.44
Asset Turnover
0.08 0.02 0.02 0.02 0.01 0.01 0.00 0.01 0.01 0.02
Operating CF/Net income
0.64 6.67 0.78 0.24 0.58 4.91 0.59 0.87 0.82 0.80
Capex/Depreciation
(0.59) (0.36) (0.18) (0.54) (0.20) (7.26) (2.72) (0.18) (0.14) (0.41)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(2,599.95%) (134.83%) (158.84%) (149.51%) (32.72%) (2.09%) (44.26%) (2,269.58%) (176.77%) (140.24%)
ROA
(53.35%) (37.59%) (64.71%) (124.18%) (31.47%) (1.80%) (27.45%) (118.96%) (93.15%) (99.08%)
ROIC
(41.00%) (22.73%) (59.59%) (60.17%) (21.83%) (12.88%) (15.89%) 0.00% (420.95%) (295.95%)
Return on Tangible Assets
159.30% (185.01%) (151.05%) (1,140.79%) (138.05%) (4.36%) (31.60%) 147.67% (169.32%) (119.75%)
Average Days of Receivables
113.23 126.24 1,171.10 333.05 426.37 478.04 3,896.45 1,151.06 1,150.42 680.35
Research and Development Expense of Revenue
46.17% 799.49% 1,940.67% 1,133.56% 1,076.32% 160.10% 2,319.23% 4,214.71% 3,954.71% 2,556.65%
Selling, General and Administrative Expense of Revenue
127.76% 991.03% 1,965.54% 1,034.33% 2,493.49% 1,413.01% 7,023.93% 4,188.24% 4,009.16% 2,629.00%
Intangible Assets out of Total Assets
0.05 0.04 0.10 0.13 0.04 0.03 0.04 0.51 0.23 0.18
Share Based Compensation of Revenue
23.80% 1,954.91% 439.87% 345.33% 837.28% 636.73% 1,654.70% 630.39% 997.12% 856.80%
Graham Net Nets
(1.08) (1.13) (0.09) (0.16) 0.07 0.03 0.14 (0.46) 0.07 0.07
Graham Number
2.47 0.00 0.00 0.00 0.00 0.00 0.00 4.97 0.00 0.00
Earnings Yield
(58.99%) (58.46%) (22.60%) (105.99%) (9.52%) (0.33%) (10.35%) (60.61%) (60.80%) (16.00%)
Free Cash Flow Yield
(41.53%) (411.20%) (20.37%) (26.97%) (5.96%) (0.97%) (5.30%) (54.72%) (48.74%) (13.21%)
Revenue per Share
0.13 0.04 0.02 0.05 0.03 0.04 0.01 0.01 0.02 0.04
Operating CF per Share
(0.52) (5.07) (0.71) (0.84) (0.87) (0.45) (0.52) (1.44) (1.87) (1.92)
Capex per Share
(0.05) (0.28) (0.02) (0.05) (0.01) (0.13) (0.02) (0.01) (0.01) (0.06)
Free Cash Flow per Share
(0.58) (5.35) (0.72) (0.89) (0.88) (0.58) (0.54) (1.44) (1.88) (1.98)
Cash per Share
0.05 0.67 0.51 0.20 1.05 2.06 2.86 0.17 1.38 1.96
Shareholders Equity per Share
(0.33) 0.64 0.63 0.58 4.15 5.34 4.37 (0.69) 0.95 1.72
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.33) 0.64 0.63 0.58 4.15 5.34 4.37 (0.69) 0.95 1.72
Free Cash Flow
(7.32) (41.80) (4.38) (4.82) (4.76) (2.98) (2.13) (3.17) (3.62) (3.61)
Working Capital
(7.66) 2.52 2.84 0.94 5.24 9.97 10.67 (2.68) 2.30 3.30
Capital Expenditures
(0.69) (2.18) (0.09) (0.27) (0.04) (0.68) (0.08) (0.01) (0.02) (0.10)
Net Current Asset Value
(19.08) (11.44) (1.91) (2.95) 5.20 9.96 5.61 (2.68) 0.56 1.80
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.42 7.96 0.69 0.99 0.30 3.46 3.25 0.46 0.41 1.57
Net Profit Margin
(629.37%) (2,167.06%) (4,037.82%) (6,969.89%) (5,982.60%) (238.78%) (14,886.75%) (11,896.73%) (11,484.03%) (6,577.58%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.98 8.68 0.64 0.67 0.30 0.12 0.08 0.35 0.39 0.67
Cash ROIC
(56.15%) (157.01%) (43.63%) (65.23%) (19.12%) (8.04%) (7.18%) 1,840.27% (65.20%) (47.98%)
Accounts Receivable Turnover
5.43 1.03 0.40 1.34 0.66 0.77 0.14 0.28 0.31 0.56
Accounts Payable Turnover
5.81 1.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
26.67 9.22 0.00 — — 0.00 — — — —
Average Days of Payables
78.04 370.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days of Inventory on Hand
19.86 58.65 0.00 — — 0.00 0.00 — — —
Average Receivables
0.30 0.27 0.34 0.21 0.21 0.25 0.17 0.11 0.12 0.12
Average Payables
1.21 0.77 0.54 0.59 0.90 0.94 0.64 0.55 0.51 0.46
Average Inventory
0.26 0.10 0.08 — — 0.10 — — — —
Average Assets
19.34 15.80 8.53 15.45 26.00 26.05 12.69 3.06 4.71 4.44
Average Common Equity
0.40 4.41 3.48 12.83 25.02 22.37 7.87 0.16 2.48 3.14

Fold the line items

Columns are period end dates